CYDY update: still looks promising to me.

OTC:CYDY   CytoDyn Inc.
There was a disappointing drop in price after my first posting. (see link below). Since then there has been very encouraging news on one of its drugs. The good news: Although in small trials, the drug appears to be very helpful in assisting treatment in severe infections with Covid-19. Bad news: multiple law firms are suing CYDY as these opportunistic firms do.
Remember: small biotech often quit volatile and risky, i.e. not for everyone.
Process your way.
Take care. Have a good week.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.